Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer and blood coagulation.

C Boccaccio1, E Medico

  • 1Division of Molecular Oncology, Institute for Cancer Research and Treatment (IRCC), University of Turin Medical School, Str. Prov. 142, 10060 Candiolo, Italy. carla.boccaccio@ircc.it

Cellular and Molecular Life Sciences : CMLS
|April 14, 2006
PubMed
Summary

Cancer development is linked to blood coagulation activation, which promotes tumor growth and invasion. Targeting blood clotting may offer a novel therapeutic strategy for cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver metastases do not predict resistance to the addition of atezolizumab to first-line FOLFOXIRI plus bevacizumab in proficient MMR metastatic colorectal cancer: a secondary analysis of the AtezoTRIBE study.

ESMO open·2025
Same author

Waiting for the "liquid revolution" in the adjuvant treatment of colon cancer patients: a review of ongoing trials.

Cancer treatment reviews·2024
Same author

An mTOR feedback loop mediates the 'flare' ('rebound') response to MET tyrosine kinase inhibition.

Scientific reports·2023
Same author

Predicting locally advanced rectal cancer response to neoadjuvant therapy with <sup>18</sup>F-FDG PET and MRI radiomics features.

European journal of nuclear medicine and molecular imaging·2019
Same author

Long-term efficacy of microbiology-driven periodontal laser-assisted therapy.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2016
Same author

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study.

Breast cancer research and treatment·2014

Area of Science:

  • Oncology
  • Hematology
  • Biochemistry

Background:

  • Blood coagulation disorders are frequently observed in cancer patients, even during early disease stages.
  • Oncogene expression and tumor suppressor gene inactivation can upregulate genes involved in blood coagulation.
  • Activation of blood clotting and subsequent fibrin deposition around tumors appear crucial for cancer progression.

Purpose of the Study:

  • To investigate the role of blood coagulation in cancer development.
  • To explore the potential of targeting coagulation pathways as a cancer therapy.

Main Methods:

  • Review of in vitro and in vivo experimental models.
  • Analysis of gene expression related to coagulation in cancer contexts.

Main Results:

  • Experimental models demonstrate that oncogene activation or tumor suppressor inactivation promotes coagulation gene expression.
  • Fibrin deposition, a result of blood clotting, forms a provisional matrix that aids tumor invasion and angiogenesis.
  • Evidence suggests a significant role for fibrin in supporting neoplastic tissue growth and blood vessel formation.

Conclusions:

  • Activation of the blood coagulation cascade is instrumental in cancer development.
  • Fibrin deposition supports tumor invasion and angiogenesis.
  • Interfering with blood coagulation presents a potential avenue for multifaceted cancer therapy.

Related Experiment Videos